Post-Reperfusion Syndrome in Liver Transplantation: incidence, predictors, and early outcomes: A Single-Center Experience : A retrosective study

Incidence, risk factors, and earliest consequences of post-reperfusion syndrome in recipients of living donor liver transplantation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202503589414736

Enrollment

105

Registered

2025-03-18

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Recipients of living donor liver transplantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1: both sexes 2; age: 18-65 3-patients who are scheduled for living donor liver transplantation with right lobe graft with complete perioperative dataavailable

Exclusion criteria

Exclusion criteria: 1: patients with incomplete records 2-acute fulminant hepatitis 3-hepato-renal syndrome 4: hepato-pulmonary syndrome

Design outcomes

Primary

Measure	Time frame
Incidence of post-reperfusion syndrome, defined as more than 30 percent drop in MAP when compared to MAP immediately before portal de-clampingfor 1 minute within the first 5 minutesafter portal declamping	—

Secondary

Measure	Time frame
identification of preoperative, intraoperative, and graft-related predictors of postreperfusion syndrome in Living donor liver transplantation	—

Countries

Egypt

Contacts

Public ContactMostafa Abdelkhalek

Lecturer Of Anesthesia and surgical intensive care Mansoura university Hospitals Mansoura university

moustafa.abdelkhale2@mans.edu.eg00201098298593

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 10, 2026